MInimal Residual Disease Adapted Strategy
Clinical trial NCT04934475 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04934475
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-08
- Primary completion
- 2024-09-30
- Enrollment
- 791
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.